NMPA Approval

Zanamivir Powder for Inhalation

Approval Number

H20140463

Registration Date

July 22, 2019

Previous Approval Numbers

H20140463

Drug Information

Generic Name

扎那米韦吸入粉雾剂

Trade Name

依乐韦

Brand Name

依乐韦

Dosage Form

吸入粉雾剂

Strength

5mg(以C12H20N4O7计)

Drug Type

化学药品

Registration Date

July 22, 2019

Expiry Date

July 21, 2024

Company Address

1061 Mountain Highway Boronia VIC 3155 Australia

Company Address

1061 Mountain Highway Boronia VIC 3155 Australia

Empowering clinical research with data-driven insights and AI-powered tools.

扎那米韦吸入粉雾剂 - NMPA 批准文号 | MedPath